The degree of respiratory depression in accordance with the concentration of remimazolam

The degree of respiratory depression in accordance with the effect-site concentration of remimazolam for target-controlled infusion

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

CRIS

Registry ID

KCT0006952

Enrollment

108

Registered

2022-01-21

Start date

2022-04-18

Completion date

Unknown

Last updated

2023-03-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

Drug : The patients are divided into 3 groups (Group 500: Ceff 500 ng/ml of TCI, Group 1000: Ceff 1000 ng/ml of TCI, Group 1500: Ceff 1500 ng/ml of TCI). After applying basic monitoring to the patien

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: The patient with American Society of Anesthesiologists classification ?2 undergoing elective surgery under general anesthesia

Exclusion criteria

Exclusion criteria: Obesity? BMI 30, Mallampatti class 3 or 4, patient with sleep apnea, pulmonary disease, recent upper airway infection within 3 weeks, liver disease (AST or ALT ? 100 U/L), or renal disease (sCr = 2 mg/dL)

Design outcomes

Primary

Measure	Time frame
Frequency of SpO2 <93%	—

Secondary

Measure	Time frame
Modified Observer’s Assessment of Alertness and Sedation scale	—

Countries

Korea, Republic of

Contacts

Public ContactHa Yeon Kim

Ajou University Hospital

dreamfy83@naver.com+82-31-219-4918

Outcome results